Track record · closed signal

Innoviva Inc (INVA) — closed signal from May 13, 2026

Partial Published before the outcome was known, scored automatically when the window closed on August 11, 2026.

Predicted vs. what happened

INVA price · publication thesis → realized outcomesplit-adjusted
$22.90 Published $27.94 Target $20.75 Window close $24.17 Peak
$22.00 – $23.25Entry zone — fair-value band
$22.90Published — price the day we called it
$27.94Target — the price the thesis aimed for
$24.17Peak — highest point inside the window, not a realized return
$20.75Window close — end-of-window price, context only

What happened

Partial

Reached 25% of the predicted growth at its peak, without hitting the target.

Peak price
$24.17
peak on June 24, 2026 — not a realized return
Peak gain
+5.5%
peak, from the publication price
Window close
$20.75
end-of-window price, context only
Days to target
Window
May 13, 2026 – August 11, 2026

The thesis — published May 13, 2026

Predicted growth
+22%
over the measurement window
Target price
$27.94
the price the thesis aimed for
Entry zone
$22.00 – $23.25
the fair-value band we waited for
Price at publication
$22.90
published May 13, 2026
Confidence
72%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Innoviva earns steady fees from drug royalties instead of depending on one big drug success. A recent research note said those fees look durable and the company's cash position is solid. Trading is light and price moves can be sharp, but the current low price and recent pullback make a short-term rebound look plausible if risks hold.

Primary drivers

  • Steady royalty fees give predictable revenue
  • Research note supports the durability of royalties
  • Large cash balance lowers need for new financing
  • Thin trading and short interest can make price swings bigger

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.